Aditya Shreenivas, MD, MS, discusses the clinical trial that led to the FDA approval of penpulimab in nasopharyngeal carcinoma.
Aditya Shreenivas, MD, MS
Aditya Shreenivas, MD, MS, is an assistant professor in the Department of Medical Oncology & Therapeutics Research at City of Hope.
Articles by Aditya Shreenivas, MD, MS
Aditya Shreenivas, MD, MS, discusses findings from the clinical trial supporting the FDA approval of penpulimab in nasopharyngeal carcinoma.